Immediate Impact

19 from Science/Nature 77 standout
Sub-graph 1 of 22

Citing Papers

Chemically Modified Platforms for Better RNA Therapeutics
2024 Standout
Overall survival with sacituzumab govitecan in hormone receptor-positive and human epidermal growth factor receptor 2-negative metastatic breast cancer (TROPiCS-02): a randomised, open-label, multicentre, phase 3 trial
2023 Standout
2 intermediate papers

Works of Abdullah Alajati being referenced

Mammary Tumor Formation and Metastasis Evoked by a HER2 Splice Variant
2013

Author Peers

Author Last Decade Papers Cites
Abdullah Alajati 355 65 162 117 17 577
Alaa T. Alshareeda 380 59 205 77 28 614
Byung‐Chul Jeong 422 29 115 108 31 705
Nicolas Gengenbacher 299 67 187 72 10 609
John M. Szymanski 311 31 127 107 14 594
Karlien Kallmeyer 207 43 203 88 10 536
Lele Zhang 209 81 229 131 13 567
Lorenzo Veschini 283 39 90 111 20 662
Neel I. Nissen 198 87 265 67 18 563
Sukhyun Song 335 57 112 85 20 664
Venkateswara Rao Gogineni 217 49 106 160 24 554

All Works

Loading papers...

Rankless by CCL
2026